Evidence map›Paper›PMID 34001560›Full record

ArticleInfection and immunity2021

Staphylococcus aureus Peptide Methionine Sulfoxide Reductases Protect from Human Whole-Blood Killing.

William N Beavers, Ashley L DuMont, Andrew J Monteith, K Nichole Maloney, Keri A Tallman, Andy Weiss, Alec H Christian, F Dean Toste, Christopher J Chang, Ned A Porter and 2 more

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Defects in anaplerotic metabolism sensitizeMicrobiology spectrum · 2025
    Article
  2. Review
  3. Review
  4. Article
  5. Quorum-sensingeLife · 2024
    Article
  6. Quorum-sensingbioRxiv : the preprint server for biology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

William N BeaversDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Ashley L DuMontDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Andrew J MonteithDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
K Nichole MaloneyDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Keri A TallmanDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee, USA.
Andy WeissDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Alec H ChristianDepartment of Chemistry, University of California, Berkeley, Berkeley, California, USA.
F Dean TosteDepartment of Chemistry, University of California, Berkeley, Berkeley, California, USA.
Christopher J ChangDepartment of Chemistry, University of California, Berkeley, Berkeley, California, USA.
Ned A PorterDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee, USA.
Victor J TorresDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Eric P SkaarDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Vanderbilt University Medical Center · USUniversity of California, Berkeley · USVanderbilt University · USNew York University · US

Funding

Vanderbilt Infection Pathogenesis and Epidemiology Research Training ProgramT32AI007474 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KALAMS, SPYROS A · 1995 to 2025
$6.9M
Methods for Selective Organic Synthesis based on Ionic CatalystsR35GM118190 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI F. Dean Toste · 2016 to 2026
$6.7M
Immunobiology of Blood and Vascular Systems Training ProgramT32HL069765 · NHLBI · VANDERBILT UNIVERSITY · PI HAWIGER, JACK J · 2002 to 2016
$6.5M
Mechanistic Studies Of The Staphylococcus aureus LukAB CytotoxinR01AI099394 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Victor J. Torres · 2013 to 2026
$6.1M
Pathobiology of heme inducible transporters in Gram positive pathogensR01AI073843 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SKAAR, ERIC P · 2009 to 2025
$5.9M
Mechanism and function of heme-iron utilization in staphylococcal pathogenesisR01AI069233 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SKAAR, ERIC P · 2006 to 2020
$5.6M
Contribution of LukED to Staphylococcus aureus pathobiologyR01AI105129 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI TORRES, VICTOR J. · 2014 to 2023
$4.9M
Host-pathogen interactions during hospital adaptation of MRSAR01AI137336 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SHOPSIN, BO, YANAI, ITAI · 2019 to 2022
$3.3M
Chemical Probes to Study Methionine Redox BiologyR01GM139245 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI Christopher J. Chang · 2020 to 2026
$2.9M
Defining the molecular inventory of staphylococcal tissue abscesses and its effects on the host-pathogen interfaceF32AI157215 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WEISS, ANDY · 2021 to 2023
$145k
The impact of dietary manganese on the immune response during Staphylococcus aureus infection of the heartF32HL144081 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MONTEITH, ANDREW J · 2018 to 2020
$143k
NHLBI NIH HHS F32 HL144081NHLBI NIH HHS T32 HL069765NIAID NIH HHS F32 AI157215NIAID NIH HHS R01 AI069233NIAID NIH HHS R01 AI073843NIAID NIH HHS R01 AI099394NIAID NIH HHS R01 AI105129NIAID NIH HHS R01 AI137336NIAID NIH HHS T32 AI007474NIGMS NIH HHS R01 GM139245NIGMS NIH HHS R35 GM118190
6 · The paper itself

Abstract

The generation of oxidative stress is a host strategy used to control Staphylococcus aureus infections. Sulfur-containing amino acids, cysteine and methionine, are particularly susceptible to oxidation because of the inherent reactivity of sulfur. Due to the constant threat of protein oxidation, many systems evolved to protect S. aureus from protein oxidation or to repair protein oxidation after it occurs. The S. aureus peptide methionine sulfoxide reductase (Msr) system reduces methionine sulfoxide to methionine. Staphylococci have four Msr enzymes, which all perform this reaction. Deleting all four

Indexed as

AnimalsDisease Models, AnimalDisease SusceptibilityHost-Pathogen InteractionsHydrogen PeroxideMethionine Sulfoxide ReductasesMiceMicrobial ViabilityMutationOxidation-ReductionOxidative StressStaphylococcal InfectionsStaphylococcus aureusHydrogen Peroxidemethionine sulfoxide reductaseMethionine Sulfoxide Reductasesmethionine sulfoxidemethionine sulfoxide reductasesMRSAoxidative stresspathogenesisStaphylococcus aureus

Identifiers

PMID34001560
PMCPMC8281210
OpenAlexW3160810670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.